Cambridge
at Home and the MIT
Museum present "Inside Cambridge Biotechnology," a lecture series
in lay language to clarify what's going on inside all those biotechnology buildings
all around Kendall Square
and elsewhere in Cambridge.
Specifically, how are these companies tackling 'difficult diseases' that either
lack treatments or need significantly more effective treatments -- at a cost of
billions of dollars in investors' money?
February
11
Dr. David Schenkein, CEO, Agios Pharmaceuticals
"Attacking the Deadly Metabolism of
Cancer Cells"
March
11
Dr. George Scangos, CEO, Biogen Idec
"Facing Up to Difficult Diseases"
April
8
Kevin Starr, Partner, Third Rock Ventures
"The Investment Crisis in Life Science."
May
13
Dr. John Maraganore, CEO, Alnylam Pharmaceuticals
“Tackling Disease With RNA Interference”
June
10
Joan
Mannick, NovartisInstitutes for BioMedical Research
"New Approaches to Treat
Aging-Related Conditions"
Time:
All lectures start at 6:00 PM
Location:
MIT Museum, 265 Massachusetts Avenue, Cambridge
(Number
1 bus stop, also near Central
Square Red Line T stop)
Open
to the public
Admission $10 ($5 for seniors) at the door
Free to Cambridge
at Home members who pre-register with the CAH office.